The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi
Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.
Sponsored by Leucentra, https://leucentra.com/
Inspired by science, empowered by IT. Leucentra helps life science and healthcare organizations evaluate, implement, and get more value from technology that supports innovation.
In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe speak with Dr. Lakshmi Amaravadi, Head of Oncology Bioanalysis at AstraZeneca, live from AAPS PharmSci 360 in San Antonio.
Dr. Amaravadi unpacks why biomarker validation is not…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.